Innuovo Technology Co Ltd

Innuovo Technology maintains a relatively strong liquidity position, with a current ratio of 2.46, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The debt-to-equity ratio of 0.16 suggests a conservative capital structure, with equity significantly outweighing debt.

Profitability metrics show a return on equity (ROE) of 2.9% and a return on assets (ROA) of 1.93%, both below the typical thresholds for high-performing chemical firms. These figures indicate that the company is generating modest returns relative to its equity and asset base. Gross profit of 193.6 million CNY and operating income of 97.5 million CNY reflect a narrow margin structure, which is common in the commodity chemicals industry but leaves little room for volatility.

The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond its primary market. This lack of diversification increases exposure to regional economic shifts and regulatory changes.

Looking ahead, the company's revenue is expected to grow, with the most recent actual revenue at 3.88 billion CNY and analyst estimates projecting EBIT of 377 million CNY. However, the growth trajectory is not yet clear, as historical revenue data does not show a consistent upward trend. Capital expenditures have been negative in the latest period, suggesting a reduction in investment in new projects or capacity expansion.

Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The risk assessment also highlights the need for close monitoring of the company's debt management and cash flow generation.

Recent events include the latest financial filing, which provides updated revenue and profit figures. No significant earnings call transcripts or regulatory filings have been disclosed that would indicate major strategic shifts or operational changes.

Innuovo Technology Co Ltd (000795.SZ) has undergone a significant update to its corporate profile, primarily marked by the formal classification of its business activities. The company is now explicitly categorized within the "Chemicals" activity and the "Basic Materials" economic sector. This taxonomic clarification provides a clearer framework for understanding the firm's operational focus and industry positioning, moving from an undefined state to a specific sectoral identity. Alongside this sectoral definition, the company’s risk profile has been initialized with specific assessments. The dilution risk is now rated as "low," indicating a stable capital structure with minimal immediate threat of share value erosion from new issuances. Conversely, the liquidity risk has been assessed as "medium," suggesting that while the company maintains operational fluidity, there are moderate considerations regarding the ease of converting assets to cash or managing short-term obligations. These changes represent the first tracked-field updates for Innuovo Technology, with the sector classification carrying a medium severity rating due to its foundational impact on investment analysis. The risk assessments, while lower in severity, provide critical baseline metrics for evaluating the company's financial health. The absence of prior values for these fields indicates that this is an initial establishment of these specific analytical parameters rather than a shift from a previous state. The significance of these updates lies in the enhanced transparency and structured data available for stakeholders. By defining Innuovo Technology within the Basic Materials sector and establishing clear risk benchmarks, investors and analysts can now more accurately compare the company against peers in the chemical industry. This structured data supports more informed decision-making, even in the absence of current analyst coverage or index membership details.

Net income surged 176.5% year-over-year to CNY 247.6 million, demonstrating significant profitability recovery.

Operating income jumped 147.9% to CNY 269.9 million, indicating strong core business performance improvement.

Debt-to-equity ratio of 0.16 is well below the cohort median of 0.31, indicating a conservative capital structure.

Free cash flow turned negative to CNY -127.2 million in FY0, signaling potential liquidity or investment pressures.

The company faces high credit risk, which could impair its ability to secure favorable financing terms.

Return on equity of 2.9% lags the Commodity Chemicals cohort median of 3.6%, suggesting inefficient capital usage.

Revenue declined 0.7% year-over-year, indicating stagnation in top-line growth despite margin improvements.

Medium liquidity risk flags potential challenges in meeting short-term obligations or operational funding needs.

Revenue ¥3.88B, −3,1% YoY; Operating income +4,8% YoY.

• ▍Revenue ¥3.88B, −3,1% YoY
• ▍Operating income +4,8% YoY
• ▍Net income +0,9% YoY
• ▍Free cash flow −203,1% YoY
• ▍Net margin 6.4%